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The need to “carer proof” healthcare decisions
Such decisions may have important effects on family carers; decision making should formally
consider them
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Population ageing and fiscal austerity are set to increase the
reliance on family carers, who already provide much of the
support for people with long term health conditions. Although
most carers are willing, providing care can be hugely stressful,
affecting mental and physical health1 and resulting in social
isolation and financial hardship.2 When under strain, carers are
less likely to be effective, increasing the risk that the care
recipient is admitted to hospital or a care home.3 Health systems
could reduce strain on family carers by routinely considering
carers’ needs alongside patients’ needs in everyday healthcare
decisions—a concept we term “carer proofing.”
Healthcare interventions (such as a new treatment or a different
way of organising care) can affect family carers in various ways
(fig 1). Healthcare interventions may reduce the physical
demands on carers or make them more (or less) anxious about
their loved one’s condition.4 And some interventions—for
example, those that target patient lifestyles— are likely to
directly affect the lifestyle of carers too.
Fig 1 How patient interventions can affect carer outcomes
Few clinical studies have collected data on both patient and
carer outcomes,5 although this is becoming more common. A
recent study of stroke follow-up care unexpectedly showed that
the intervention reduced carer depression but did not affect
patient outcomes.6 Conversely, a trial of reminiscence therapy
for dementia concluded that though quality of life may have
improved for people with dementia who attended the sessions,
carers’ anxiety increased significantly.7 Other interventions,
such as the closure of mental health beds or the promotion of
activity among frail older people, could also benefit patients at
the expense of carers.
From a research point of view, there needs to be a twin focus
on collecting more data on the effect of patient interventions on
carers, and routinely using these data to inform reviews,
meta-analyses, and economic evaluations. This would help to
determine the effectiveness and efficiency of interventions more
comprehensively. Better evidence would also provide a stronger
foundation for carer proofing policymaking and clinical decision
making. The National Institute for Health and Care Excellence
(NICE) already stipulates that economic evaluations of new
healthcare interventions should consider carers’ health outcomes
as well as patients’.8 This is rarely done,9 although recent
methodological advances10 11 ought to support this practice.
At the policy level, how care is organised for people with long
term conditions can profoundly affect the lives of carers. The
notion of integrated health and care services, for example, holds
the hope of reducing the stress that carers experience from lack
of joined up care. On the other hand, integrated services might
be concentrated on fewer but larger sites, resulting in greater
travelling time and less personal service for already stressed
family carers.
At the clinical level, guidelines often recommend involving
carers in care decisions, where possible. Nonetheless, carers
may get squeezed out because of lack of patient consent or busy
clinical schedules. If the clinical decision affects the carer, this
ought to be taken into account in order to ensure good adherence
to the treatment plan. Carer proofing is likely to be particularly
valuable at times of change, such as around diagnosis or when
someone takes an active caring role.12
Enhanced carer proofing could complement existing
interventions to support carers, such as respite care, carer support
groups, and individual education and training. One problem
with existing forms of carer support is that the interventions
often come too late, with carer stress treated as an inevitable
side effect of the patient’s condition. To support carers better,
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carer outcomes should be considered in healthcare decisions
for long term conditions from the outset (table⇓).
Carer proofing challenges researchers to provide better evidence
of the effectiveness and efficiency of interventions from the
perspective of all those affected. It also challenges care
professionals and policy makers to focus their thinking on how
the wellbeing of the patient-carer dyad could be optimised.
There is both a moral and a practical imperative to consider
carers in healthcare decisions given the vital role they have in
supporting the health system.
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Table
Table Table| Examples of carer proofing measures that healthcare decision makers could take
Future measuresImmediate measuresType of decision
Further develop approaches to evidence synthesis and economic
evaluation that enable inclusion of carer and patient outcomes and
balancing their needs when these are in tension
Collect data on carer outcomes in clinical trials and include these
data in subsequent evidence syntheses and economic evaluations
Research decisions
Develop mechanisms that promote a joined-up approach across
sectors and organisations to identify and support family carers
Apply a “carer impact” test to major organisational changes, such as
initiatives to integrate health and social care
National policy decisions
Evidence based decision making to optimise the outcomes for the
patient-carer dyad
Involve the family carer when treatment regimens are to be changed,
especially when carer is taking on a more active role or patient
capacity starts to decline
Clinical decisions
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